PODD Assumes Neutral Rating by UBS -- Price Target Set at $174.0

UBS has downgraded Insulet (PODD) to a Neutral rating from Buy, setting a new price target of $174.00. Despite this, GuruFocus indicates PODD is significantly undervalued with a GF Value™ of $401.48 and boasts a strong GF Score™ of 81/100, driven by excellent growth and profitability. Mixed sentiment from institutional investors and net insider buying suggests a cautious yet potentially attractive investment opportunity due to its undervaluated status.